NSF awards Arts and Sciences startup $1 million to complete R&D on antimicrobial and antiviral agent

ZeoVation — an Ohio State startup co-founded by Prabir Dutta, Distinguished University Professor Emeritus in the Department of Chemistry and Biochemistry, and Bo Wang PhD ’16 — has been awarded $1 million in Small Business Innovation Research (SBIR) Phase II funding from the National Science Foundation, as a follow-on from its $225,000 Phase I. This funding will enable ZeoVation to complete research and development work on an antimicrobial and antiviral agent to combat the proliferation of antibiotic resistant bacteria and viruses, including the SARS-CoV-2 virus, and scale manufacturing and complete the testing necessary to bring the product to market.